» Authors » Alexander Kopp

Alexander Kopp

Explore the profile of Alexander Kopp including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 112
Citations 3164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Paiwand S, Schafer S, Kopp A, Beikler T, Fiedler I, Gosau M, et al.
Int J Implant Dent . 2025 Feb; 11(1):12. PMID: 39960576
Peri-implantitis is known as an inflammatory condition affecting the soft and hard tissue around dental implants. A promising strategy to prevent these conditions is the use of antibacterial implants. This...
2.
Isella B, Hassan N, Drinic A, Eickhoff R, Kroger N, Vaughan T, et al.
J Biomed Mater Res B Appl Biomater . 2025 Jan; 113(2):e35499. PMID: 39888215
Biliary duct reconstruction is one of the most challenging parts of liver transplantation and accounts for 40%-60% of complications. While current stent-based devices on the market show promising results in...
3.
Muller E, Schoberwalter T, Mader K, Seitz J, Kopp A, Baranowsky A, et al.
Biomater Res . 2024 Dec; 28:0122. PMID: 39717475
Magnesium (Mg)-based implants have evolved as a promising innovation in orthopedic trauma surgery, with the potential to revolutionize the treatment of bone diseases, including osteoporotic fractures and bone defects. Available...
4.
Quinn C, Van Gaalen K, McHugh P, Kopp A, Vaughan T
Comput Biol Med . 2024 Nov; 184:109444. PMID: 39608034
This study presents a multi-domain computational framework to investigate the long-term performance of permanent and bioabsorbable magnesium fixation devices in orthopaedic fracture applications. The framework integrates a coupled model for...
5.
Wu C, Shah B, Sharma A, Sheng Y, Liu P, Kopp A, et al.
Eur J Heart Fail . 2024 Sep; 27(2):307-316. PMID: 39267410
Aims: Results from randomized trials suggest benefit of sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation in clinically stable acute heart failure. We aim to examine the real-world effectiveness of early versus...
6.
Ruco A, Lofters A, Lu H, Baxter N, Guilcher S, Kopp A, et al.
BMC Cancer . 2024 Sep; 24(1):1114. PMID: 39243029
Background: Lung cancer is one of the most common cancers and causes of cancer death in Canada. Some previous literature suggests that socioeconomic inequalities in lung cancer screening, treatment and...
7.
Ruangsomboon O, Zhong A, Kopp A, Elston B, Eldridge K, Lee S, et al.
Healthc Policy . 2024 Sep; 19(4):42-54. PMID: 39229662
The COVID-19 pandemic significantly impacted primary care, but its effect on quality of care is not well understood. We used health administrative data to understand the changes in quality-of-care measures...
8.
Ali W, Ordono J, Kopp A, Gonzalez C, Echeverry-Rendon M, Llorca J
J Biomed Mater Res A . 2024 Jun; 112(12):2136-2148. PMID: 38899796
Bioabsorbable Mg wire-reinforced poly-lactic acid (PLA) matrix composites are potential candidate for load-bearing orthopedic implants offering tailorable mechanical and degradation properties by stacking sequence, volume fraction and surface modification of...
9.
Hassan N, Krieg T, Kopp A, Bach A, Kroger N
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892430
Magnesium-based biomaterials hold remarkable promise for various clinical applications, offering advantages such as reduced stress-shielding and enhanced bone strengthening and vascular remodeling compared to traditional materials. However, ensuring the quality...
10.
Junek M, Barra L, Kopp A, Felfeli T, Gatley J, Widdifield J
J Rheumatol . 2024 Apr; 51(7):696-702. PMID: 38561188
Objective: To estimate the additional healthcare system costs associated with giant cell arteritis (GCA) in the 1-year prediagnosis and postdiagnosis periods and over long-term follow-up compared to individuals with similar...